DivAirCity Social Health Survey
Launched by CHARITE UNIVERSITY, BERLIN, GERMANY · Feb 15, 2024
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
The DivAirCity Social Health Survey is a research study focused on helping people living in cities manage stress better. The goal is to see if improvements like reducing noise and improving air quality can lead to less psychological stress and better overall well-being. In this trial, researchers will measure stress levels and health factors before and after these changes are made in five different cities. They will compare the results from areas where improvements are made (called intervention sites) to areas where no changes are made (called control sites).
To participate, individuals need to live or work near the locations where changes are being implemented or at a control site. There are no specific exclusions, so almost anyone can join if they qualify. Participants can expect to share their experiences and undergo assessments related to their stress and health at the beginning and after the changes are made. This study aims to find out how effective these improvements can be in making urban life healthier and less stressful for everyone.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Participants must live or work at or near the installation (intervention group) or control site (control group)
- Exclusion Criteria:
- • none
About Charite University, Berlin, Germany
Charité - Universitätsmedizin Berlin is a leading academic medical center in Germany, renowned for its commitment to excellence in research, education, and patient care. As one of Europe's largest university hospitals, Charité integrates cutting-edge clinical practices with innovative research initiatives, fostering interdisciplinary collaboration across various medical fields. The institution is dedicated to advancing healthcare through rigorous clinical trials, contributing to the development of new therapies and treatment protocols. With a strong emphasis on translational medicine, Charité aims to bridge the gap between scientific discovery and practical application, ultimately enhancing patient outcomes and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Berlin, , Germany
Patients applied
Trial Officials
Andreas Michalsen, Prof MD
Principal Investigator
Charite Universitaetsmedizin Berlin
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported